Evidence map›Paper›PMID 34691815›Full record

ArticleJournal of gastric cancer2021

Successful Treatment of Advanced Gastric Cancer with Brain Metastases through an Abscopal Effect by Radiation and Immune Checkpoint Inhibitor Therapy.

Momotaro Muto, Hirotaka Nakata, Kenichi Ishigaki, Shion Tachibana, Moe Yoshida, Mizue Muto, Nobuyuki Yanagawa, Toshikatsu Okumura

Abstract readCase Reports
In one paragraph

Article in Journal of gastric cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Momotaro MutoDepartment of Internal Medicine, Engaru Kosei General Hospital, Engaru, Japan.
Hirotaka NakataDepartment of Internal Medicine, Engaru Kosei General Hospital, Engaru, Japan.
Kenichi IshigakiDepartment of Internal Medicine, Engaru Kosei General Hospital, Engaru, Japan.
Shion TachibanaDepartment of Internal Medicine, Engaru Kosei General Hospital, Engaru, Japan.
Moe YoshidaDepartment of Internal Medicine, Engaru Kosei General Hospital, Engaru, Japan.
Mizue MutoDepartment of Internal Medicine, Engaru Kosei General Hospital, Engaru, Japan.
Nobuyuki YanagawaDepartment of Internal Medicine, Engaru Kosei General Hospital, Engaru, Japan.
Toshikatsu OkumuraDivision of Metabolism, Systemic Bioscience, Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, Asahikawa, Japan.ORCID https://orcid.org/0000-0003-1810-007X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The abscopal effect refers to the phenomenon in which local radiotherapy is associated with the regression of metastatic cancer that is distantly located from the irradiated site. Here, we present a case of a patient with advanced gastric cancer and brain metastases who was successfully treated with brain radiotherapy and anti-programmed death-1 (PD-1) therapy-induced abscopal effect. Although anti-PD-1 therapy alone could not prevent disease progression, the metastatic lesions in the brain and also in the abdominal lymph node showed a drastic response after brain radiotherapy and anti-PD-1 therapy. To our knowledge, this is the first reported case of successful treatment of advanced gastric cancer with multiple brain and abdominal lymph node metastases, possibly through anti-PD-1 therapy combined with brain radiotherapy-induced abscopal effect. We suggest that the combination of brain radiotherapy and anti-PD-1 therapy may be considered as a therapeutic option for advanced gastric cancer, especially when there is brain metastasis.

Indexed as

Abscopal effectBrain metastasisGastric cancerImmune checkpoint inhibitorRadiation

Identifiers

PMID34691815
PMCPMC8505119

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.